Stockholders’ Deficit - Schedule of Warrants Activity (Details) - Warrant [Member] - $ / shares |
3 Months Ended | 12 Months Ended | |
|---|---|---|---|
Sep. 30, 2026 |
Jun. 30, 2026 |
Jun. 30, 2025 |
|
| Schedule of Warrants Activity [Line Items] | |||
| Shares Outstanding, Ending Balance | 12,145,917 | 12,145,917 | 12,145,917 |
| Common Stock Issuable, Ending Balance | 12,145,917 | 12,145,917 | 12,145,917 |
| Weighted average grant date fair value, Ending Balance | $ 11.5 | $ 11.5 | $ 11.5 |
| Weighted average remaining contractual term, Ending Balance | 2 years 11 months 26 days | 3 years 2 months 26 days | 4 years 2 months 26 days |
| Warrants Outstanding, Granted | |||
| Common Stock Issuable, Granted | |||
| Weighted Average Exercise Price, Granted (in Dollars per share) | |||
| Average Remaining Contractual Life, Granted | |||
| Warrants Outstanding, Forfeited | |||
| Common Stock Issuable, Forfeited | |||
| Weighted Average Exercise Price, Forfeited (in Dollars per share) | |||
| Warrants Outstanding, Exercised | |||
| Common Stock Issuable, Exercised | |||
| Weighted Average Exercise Price, Exercised (in Dollars per share) | |||
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment AwardE quity Instruments Other Than Options Forfeited Weighted Average Exercise Price. No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment AwardE quity Instruments Other Than Options Granted Weighted Average Exercise Price. No definition available.
|
| X | ||||||||||
- Definition Share Based Compensation Arrangement By Share Based Payment AwardE quity Instruments Other Than Options Weighted Average Exercise Price. No definition available.
|
| X | ||||||||||
- Definition Common stock issuable, balance No definition available.
|
| X | ||||||||||
- Definition The number of common stock issuable, exercised. No definition available.
|
| X | ||||||||||
- Definition The number of common stock issuable forfeited. No definition available.
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). No definition available.
|
| X | ||||||||||
- Definition Weighted average exercise price. No definition available.
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for equity-based awards excluding options, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. No definition available.
|
| X | ||||||||||
- Definition Warrants outstanding, exercised. No definition available.
|
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The number of equity-based payment instruments, excluding stock (or unit) options, that were forfeited during the reporting period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of grants made during the period on other than stock (or unit) option plans (for example, phantom stock or unit plan, stock or unit appreciation rights plan, performance target plan). Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of non-vested equity-based payment instruments, excluding stock (or unit) options, that validly exist and are outstanding as of the balance sheet date. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted-average contractual term remaining for equity-based award excluding option, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|